Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Less CPAP time linked to exacerbation in COPD/OSA overlap syndrome

Publish date:: September 12, 2019

Key clinical point: Among patients with COPD and OSA, lung function and CPAP use are independent predictors of COPD exacerbations and all‐cause mortality.

Major finding: The average time of CPAP use was significantly higher in patients with no recorded exacerbation: 285.4 min/night vs. 238.2 min/night.

Study details: A retrospective cohort study that included 92 patients with overlap syndrome who had a COPD exacerbation and 92 patients with overlap who did not.

Disclosures: The authors had no conflicts of interest.

Citation:

Jaoude P et al. Clin Respir J. 2019 Aug 22. doi: 10.1111/crj.13079.

This Week's Must Reads

Consider potential cognitive complications prior to androgen deprivation therapy,

Diabetes raises risk of prostate cancer mortality in obese men,

Salivation inhibition fails to reduce radioiodine toxicity in prostate cancer,

Highest positive surgical margin predicts poor survival after prostatectomy,

Young minority men are underinformed about prostate cancer screening,

Must Reads in Pulmonology

Less CPAP time linked to exacerbation in COPD/OSA overlap syndrome,

Electronically Delivered Interventions in Antibiotic Rx, BMJ; ePub 2019 Feb 13; Gulliford, et al

Physician Care for Patients with COPD, CHEST; ePub 2019 Jan 18; Cho, Mecredy, et al

Venous Thromboembolism Risk in US Hospitals, Am J Med; ePub 2019 Jan 16; Huang, et al

Prescribed Opioids & Risk of CAP in Patients with HIV, JAMA Intern Med; 2019 Jan 7; Edelman, et al